Inno Bio Ventures

Inno Bio Ventures is a Malaysian government-linked biotechnology company focused on the development and manufacturing of biopharmaceuticals. The company operates through its subsidiaries, most notably Inno Biologics, which provides contract manufacturing and development services (CDMO) specializing in mammalian cell culture technology. Inno Bio Ventures aims to establish Malaysia as a hub for biologics by producing biosimilars and providing end-to-end services from upstream development to downstream processing. Their portfolio includes the development of biosimilar monoclonal antibodies and recombinant proteins for various therapeutic areas including oncology and autoimmune disorders.